Weed Stocks Skyrocket, Could There Be More Upside? Analyst Draws Scenarios
Portfolio Pulse from Nicolás Jose Rodriguez
The Department of Health and Human Services (HHS) has suggested that the DEA reclassify cannabis as a Schedule III controlled substance, triggering a rally in cannabis stocks. Zuanic & Associates (Z&A), a leading cannabis equity research firm, has outlined potential scenarios for the future of the cannabis market. Stocks and ETFs such as AdviserShares Pure US Cannabis ETF (NYSE:MSOS), the ETFMG Alternative Harvest ETF (NYSE:MJUS), Canopy Growth Corporation (NASDAQ:CGC), Curaleaf Holdings, Inc. (OTC:CURLF), Tilray, Inc. (NASDAQ:TLRY), Cresco Labs, Inc. (OTC:CRLBF), Green Thumb Industries Inc. (OTC:GTBIF), and Trulieve Cannabis Corp. (OTC:TCNNF) surged following the news.
September 01, 2023 | 7:49 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Canopy Growth Corporation's stock surged following the HHS's suggestion to reclassify cannabis.
The potential reclassification of cannabis could lead to increased business opportunities for Canopy Growth Corporation, potentially boosting its stock value.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Cresco Labs, Inc.'s stock surged following the HHS's suggestion to reclassify cannabis.
The potential reclassification of cannabis could lead to increased business opportunities for Cresco Labs, Inc., potentially boosting its stock value.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Curaleaf Holdings, Inc.'s stock surged following the HHS's suggestion to reclassify cannabis.
The potential reclassification of cannabis could lead to increased business opportunities for Curaleaf Holdings, Inc., potentially boosting its stock value.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Green Thumb Industries Inc.'s stock surged following the HHS's suggestion to reclassify cannabis.
The potential reclassification of cannabis could lead to increased business opportunities for Green Thumb Industries Inc., potentially boosting its stock value.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
The ETFMG Alternative Harvest ETF surged following the HHS's suggestion to reclassify cannabis.
The potential reclassification of cannabis could lead to increased business opportunities for companies in the cannabis sector, potentially boosting the value of the ETF.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
AdviserShares Pure US Cannabis ETF surged following the HHS's suggestion to reclassify cannabis.
The potential reclassification of cannabis could lead to increased business opportunities for companies in the cannabis sector, potentially boosting the value of the ETF.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Trulieve Cannabis Corp.'s stock surged following the HHS's suggestion to reclassify cannabis.
The potential reclassification of cannabis could lead to increased business opportunities for Trulieve Cannabis Corp., potentially boosting its stock value.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Tilray, Inc.'s stock surged following the HHS's suggestion to reclassify cannabis.
The potential reclassification of cannabis could lead to increased business opportunities for Tilray, Inc., potentially boosting its stock value.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80